Carbohydrate metabolic disturbances and obstructive sleep apnea syndrome

Cite item

Full Text


The paper analyzes an association between obstructive sleep apnea syndrome (OSAS) and carbohydrate metabolic disturbances. It presents the data of clinical trials that consider OSAS as a risk factor of type 2 diabetes mellitus (T2DM). The most important factors influencing the progression of carbohydrate metabolic disturbances in patients with OSAS are analyzed. Whether OSAS can be corrected as a modifiable risk factor in patients with T2DM is considered.

Full Text

Нарушения углеводного обмена и синдром обструктивного апноэ во сне. - Аннотация. Анализируется взаимосвязь синдрома обструктивного апноэ во сне (СОАС) и нарушений углеводного обмена. Представлены данные клинических исследований, в которых СОАС рассматривается как фактор риска развития сахарного диабета 2-го типа (СД2). Приведен анализ наиболее значимых факторов, влияющих на прогрессирование нарушений углеводного обмена у пациентов с СОАС. Рассматривается возможность коррекции СОАС у больных СД2 в качестве модифицируемого фактора риска.


  1. Рунихин А.Ю., Новикова Ю.В. Современные аспекты патогенеза и лечения сахарного диабета 2 типа. Рус мед журн 2007; 27: 2060-2065.
  2. Resnick H.E., Redline S., Shahar E. et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003; 26: 702-709.
  3. Бузунов Р.В. Синдром обструктивного апноэ сна в сочетании с ожирением: особенности патогенеза, диагностики и лечения: Дис. ... д-ра мед. наук. М 2003; 208.
  4. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respirat Critical Care Med 2002; 165 (9): 1217-1239.
  5. Manser R.M., Rochford P., Pierce R.J. et al. Impact for defining hypopneas in the Panea-Hypopnea Index. Chest 2001; 120: 909-914.
  6. Knutson K.L., Spiegel K., Penev P., Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11 (3): 163-178.
  7. Marin J.M., Carrizo S.J., Vicente E. et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
  8. Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.
  9. Einhorn D., Stewart D.A., Erman M.K. et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007; 13: 355-362.
  10. Marshall N., Keith K., Wong M. et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton study? J Clin Sleep Med 2009; 5 (1): 15-20.
  11. Roncksley P.E., Hemmelgarn B.R., Heitman S.J. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009; 64: 834-839.
  12. West S.D., Nicoll D.J., Wallace T.M. et al. Obstructive sleep apnea in men with type 2 diabetes: a double blind randomized controlled trial of the effects of CPAP on HbA1c and insulin resistance [abstract]. Paper presented at: the American Thoracic Society Meeting; May 19-24, 2006; San Diego, CA.
  13. Foster G.E., Kuna S.T., Sanders M.H. et al. Sleep apnea in obese adults with type 2 diabetes: baseline results from sleep AHEAD study [abstract]. Sleep 2005; 25: 066.
  14. Tsai W.H. Obstructive sleep apnea is associated with diabetes in sleepy subjects. Thorax 2009; 64 (10): 834-839.
  15. Reichmuth K.J., Austin D., Skatrud J.B. et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172: 1590-1598.
  16. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.
  17. Young T., Palta M., Dempsey J. et al. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328 (17): 1230-1235.
  18. Bixler E.O., Vgontzas A.N., Lin H.-M. et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Critical Care Med 2001; 163 (3.1): 608-613.
  19. Redline S., Kump K., Tishler P.V. et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Critical Care Med 1994; 149 (3.1): 722-726.
  20. Newman A.B., Nieto F.J., Guidry U. et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 1995; 154 (1): 50-59.
  21. Young T., Shahar E., Nieto F.J. et al. Predictors of sleepdisordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162 (8): 893-900.
  22. Bixler E.O., Vgontzas A.N., Ten Have T. et al. Effects of age on sleep apnea in men. Prevalence and severity. Am J Respir Critical Care Med 1998; 157 (1): 144-148.
  23. Duran J., Esnaola S., Rubio R., Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Critical Care Med 2001; 163 (3.1): 685-689.
  24. Redline S., Tishler P.V., Hans M.G. et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Critical Care Med 1997; 155(1): 186-192.
  25. Surani S., Aguillar R., Komari V. et al. Influence of Hispanic ethnicity in prevalence of diabetes mellitus on sleep apnea and relationship to sleep phase. Postgraduate Med 2009; 121 (15): 108-112.
  26. Punjabi N.M., Sorkin J.D., Katzel L.I. et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Critical Care Med 2002; 165 (5): 677-682.
  27. Guilleminault C., Bassiri A., Caskadon M.A. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and upper airway resistance syndrome. In: Kryger M.H., Roth T., Dement W.C. (eds) Principles and Practice of Sleep Medicine, 2nd ed. Philadelphia: Elsevier Saunders 2005: 1043-1052.
  28. Bliwise D.L., Feldman D.E., Bliwise N.G. et al. Risk factor for sleep disordered breathing in heterogeneous geriatric populations. J Am Geriatr Society 1987; 35 (2): 132-141.
  29. Foster G.E., Sanders M.H., Millman R. et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009; 32 (6): 1017-1039.
  30. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Applied Physiol 2005; 99 (5): 1998-2007.
  31. Punjabi N.M., Shahar E., Redline S. et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521-530.
  32. Harsch I.A., Schahin S.P., Radespiel-Troger M. et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162.
  33. Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.
  34. Ip M.S.M., Lam B., Ng M.M.T. et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Critical Care Med 2002; 165 (5): 670-676.
  35. Meslier N., Gagnadoux F., Giraud P. et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.
  36. Somers V.K., Dyken M.E., Clary M.P., Abbound F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
  37. Polotsky V.Y., Li J., Punjabi N.M. et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (1): 253-264.
  38. Botros N., Concato J., Mohsenin V. et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009; 122 (12): 1122-1127.
  39. Shin C., Kim J. et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 2005; 171: 287-291.
  40. Joo S., Lee S., Choi H.A. et al. Habitual snoring is associated with elevated hemoglobin A1c levels in non-obese middle-aged adults. J Sleep Res 2006; 15: 437-444.
  41. Peltier A.C., Consens F.B., Sheikh K. et al. Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med 2007; 8: 149-155.
  42. Kono M., Tatsumi K., Saibara T. et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392.
  43. Shaw J.E., Punjabi N.M., Wilding J.P. et al. Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81: 2-12.
  44. Oltmanns K.M., Gehring H., Rudolf S. et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169: 1231-1237.
  45. Cutler M.J., Swift N.M., Keller D.M. et al. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 2004; 96: 754-761.
  46. Mallon L., Broman J.E., Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28: 2762-2767.
  47. Yaggi K., Araujo A., McKinlay J. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29: 657-661.
  48. Tasali E., Ip M.S.M. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008; 5 (2): 207-217.
  49. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.
  50. Coughlin S.R., Mawdsley L., Mugarza J.A. et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9): 735-741.
  51. Levy P., Bonsignore M.R., Eckel J. Sleep, sleepdisordered breathing andmetabolic consequences. Eur Respirat J 2009; 34 (1): 243-260.
  52. Makino S., Handa H., Suzukawa K. et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64: 12-19.
  53. Davies R., Turner R., Crosby J. et al. Plasma insulin and lipid levels in untreated obstructive sleep apnea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180-185.
  54. Gruber A., Horwood F., Sithole J. et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22.
  55. Sharma S.K., Kumpawat S., Goel A. et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007; 8: 12-17.
  56. Vgontzas A.N., Legro R.S., Bixler E.O. et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metabol 2001; 86 (2): 517-520.
  57. Theorell-Haglow J., Berne C., Janson C., Lindberg E. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008; 31: 1054-1060.
  58. Manzella D., Parillo M., Razzino T. et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Intern J Obes 2002; 26 (3): 370-375.
  59. Zhang L.Q., Yao W.Z., Wang Y.Z. et al. Relationship between obstructive sleep apnea/hypopnea syndrome and insulin resistance. Zhonghua Nei Ke Za Zhi 2006; 45 (3): 184-187.
  60. Leproult R., Copinschi G., Buxton O., Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997; 20 (10): 865-870.
  61. Strohl K.P. Diabetes and sleep apnea. Sleep 1996; 19: S225-S228.
  62. Ip M.S.M. Obstructive sleep apnoea, insulin resistance and sleepiness. Thorax 2008; 63: 939-940.
  63. Barcelo A., Barbe F., de la Pena M. et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946-950.
  64. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. The Lancet 1999; 354 (9188): 1435-1439.
  65. Bopparaju S., Surani S. Sleep and Diabetes. Review article. Intern J Endocrinol 2010; 2010: 1-9.
  66. Kruszynska Y.T., Worrall D.S., Ofrecio J. et al. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 2002; 87 (1): 226-234.
  67. Nieto F.J., Young T.B., Lind B.K. et al. Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14): 1829-1836.
  68. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15 (11): 2792-2800.
  69. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
  70. Zhan G., Serrano F., Fenik P. et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005; 172: 921-929.
  71. Furukawa S., Fujita T., Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
  72. Laight D.W., Desai K.M., Gopaul N.K. et al. Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat. Br J Pharmacol 1999; 128: 269-271.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail:


© 2018-2021 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies